Nyxoah's (NYXH) Sell (D-) Rating Reaffirmed at Weiss Ratings

Key Points

• Nyxoah's stock has received a "sell (D-)" rating from Weiss Ratings, indicating ongoing concerns about the company's performance.
• For its latest quarter, Nyxoah reported a loss of ($0.63) earnings per share, slightly missing analyst expectations, with revenues of $1.58 million.
• Institutional investors have shown increased interest in Nyxoah, with significant holdings growth noted from Kovack Advisors and Bank of America Corp DE in the recent quarters.

Nyxoah (NASDAQ:NYXH - Get Free Report)'s stock had its "sell (d-)" rating reiterated by equities research analysts at Weiss Ratings in a research note issued on Saturday,Weiss Ratings reports.

Nyxoah Stock Performance

Nyxoah stock opened at $5.61 on Friday. The firm's fifty day moving average price is $5.65 and its 200-day moving average price is $6.62. The company has a debt-to-equity ratio of 0.29, a quick ratio of 2.38 and a current ratio of 2.63. The stock has a market cap of $191.08 million, a P/E ratio of -2.44 and a beta of 1.53. Nyxoah has a fifty-two week low of $4.34 and a fifty-two week high of $11.87.

Nyxoah (NASDAQ:NYXH - Get Free Report) last posted its quarterly earnings data on Monday, August 18th. The company reported ($0.63) earnings per share for the quarter, missing the consensus estimate of ($0.62) by ($0.01). The company had revenue of $1.58 million for the quarter, compared to analysts' expectations of $1.33 million. Nyxoah had a negative net margin of 1,541.84% and a negative return on equity of 79.18%. On average, equities research analysts expect that Nyxoah will post -1.91 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Nyxoah

Institutional investors and hedge funds have recently made changes to their positions in the business. Kovack Advisors Inc. grew its holdings in shares of Nyxoah by 16.5% during the 1st quarter. Kovack Advisors Inc. now owns 23,295 shares of the company's stock valued at $163,000 after purchasing an additional 3,295 shares during the last quarter. Shay Capital LLC bought a new position in shares of Nyxoah during the 2nd quarter valued at $374,000. Raymond James Financial Inc. bought a new position in shares of Nyxoah during the 2nd quarter valued at $70,000. Bank of America Corp DE grew its holdings in shares of Nyxoah by 72.4% during the 2nd quarter. Bank of America Corp DE now owns 7,866 shares of the company's stock valued at $59,000 after purchasing an additional 3,303 shares during the last quarter. Finally, Franklin Resources Inc. grew its holdings in shares of Nyxoah by 0.9% during the 2nd quarter. Franklin Resources Inc. now owns 294,990 shares of the company's stock valued at $2,207,000 after purchasing an additional 2,655 shares during the last quarter.

About Nyxoah

Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.